心血管疾病的风险因素、合并症及预防：勿忘首要病因！
Risk Factors, Comorbidities, and Prevention of Cardiovascular Diseases: Don't Forget the Primary Cause!
作者信息
Roubille François
机构信息
PhyMedExp, Cardiology Department, University of Montpellier, INSERM U1046, CNRS UMR, 9214, INI-CRT, 34090 Montpellier, France.
出版信息
J Clin Med. 2024 Nov 6;13(22):6652. doi: 10.3390/jcm13226652.
Abstract
Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide. Despiteinnovative treatments, both pharmacological and interventional, CVDs continue toprogress. This is largely due to the increased incidence of diseases such as diabetes andother well-established cardiovascular risk factors, as well as cumulative comorbidities andemerging risk factors.
摘要
心血管疾病（CVDs）仍然是全球主要的死亡原因。尽管有创新的治疗方法，包括药物治疗和介入治疗，但心血管疾病仍在持续发展。这主要归因于糖尿病等疾病以及其他公认的心血管危险因素的发病率增加，以及累积的合并症和新出现的危险因素。
相似文献
1
Risk Factors, Comorbidities, and Prevention of Cardiovascular Diseases: Don't Forget the Primary Cause!心血管疾病的风险因素、合并症及预防：勿忘首要病因！
J Clin Med. 2024 Nov 6;13(22):6652. doi: 10.3390/jcm13226652.
2
Association between mortality and cardiovascular diseases in the vulnerable Mexican population: A cross-sectional retrospective study of the COVID-19 pandemic.墨西哥脆弱人群的死亡率与心血管疾病之间的关联：COVID-19 大流行的横断面回顾性研究。
Front Public Health. 2022 Nov 10;10:1008565. doi: 10.3389/fpubh.2022.1008565. eCollection 2022.
3
The burden of Cardiovascular diseases in Jordan: a longitudinal analysis from the global burden of disease study, 1990-2019.约旦的心血管疾病负担：来自全球疾病负担研究，1990-2019 年的纵向分析。
BMC Public Health. 2024 Mar 21;24(1):879. doi: 10.1186/s12889-024-18316-0.
4
[Knowledge of patients from the rural environment on the risk factors and prevention of cardiovascular diseases].[农村地区患者对心血管疾病危险因素及预防的认知]
Pol Merkur Lekarski. 2010 Mar;28(165):203-6.
5
The incidence, mortality and disease burden of cardiovascular diseases in China: a comparative study with the United States and Japan based on the GBD 2019 time trend analysis.中国心血管疾病的发病率、死亡率及疾病负担：基于全球疾病负担研究（GBD）2019时间趋势分析与美国和日本的比较研究
Front Cardiovasc Med. 2024 Sep 18;11:1408487. doi: 10.3389/fcvm.2024.1408487. eCollection 2024.
6
Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15-39 years in 204 countries/territories, 1990-2019: a systematic analysis of Global Burden of Disease Study 2019.204 个国家/地区 1990 年至 2019 年 15-39 岁青少年和青年心血管疾病全球、区域和国家负担：2019 年全球疾病负担研究的系统分析。
BMC Med. 2023 Jun 26;21(1):222. doi: 10.1186/s12916-023-02925-4.
7
Mediterranean Diet for Primary and Secondary Prevention of Cardiovascular Disease and Mortality: An Updated Systematic Review.地中海饮食对心血管疾病和死亡率的一级和二级预防作用：一项更新的系统性综述。
Nutrients. 2023 Jul 28;15(15):3356. doi: 10.3390/nu15153356.
8
A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes.心血管疾病、相关风险因素及当前治疗方案简述
Curr Pharm Des. 2019;25(38):4063-4084. doi: 10.2174/1381612825666190925163827.
9
Don't forget eclampsia in the efforts to reduce maternal morbidity and mortality.在努力降低孕产妇发病率和死亡率的过程中，不要忘记子痫。
Int J Gynaecol Obstet. 2021 Feb;152(2):165-171. doi: 10.1002/ijgo.13530. Epub 2021 Jan 11.
10
Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities.口服雄激素信号抑制剂治疗合并心血管合并症的晚期前列腺癌男性患者的死亡率和住院风险。
Eur Urol. 2020 Feb;77(2):158-166. doi: 10.1016/j.eururo.2019.07.031. Epub 2019 Aug 13.
引用本文的文献
1
Advances in the treatment of atherosclerotic plaque based on nanomaterials.基于纳米材料的动脉粥样硬化斑块治疗进展
Nanomedicine (Lond). 2025 Apr;20(8):869-881. doi: 10.1080/17435889.2025.2480049. Epub 2025 Mar 20.
Zotero 插件